Qlucore Moves into Precision Diagnostics
Qlucore is expanding its bioinformatics software business into precision medicine and precision diagnostics.
Read MoreSearch Results for: lung cancer
Thermo Fisher Scientific Signs Agreement with Janssen to Codevelop Companion Diagnostic for Cancer
Thermo Fisher Scientific will collaborate with Janssen scientists to validate multiple biomarkers, which will be used to identify variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer.
Read MoreT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
Sperzel succeeds John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More
Targeted Cancer Medicine Offers Hope for Neuroblastoma Treatment
Targeted cancer treatment using an ALK inhibitor in combination with a PIM1 inhibitor can increase the chances of survival of children with an unfavorable prognosis.
Read MoreT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More